Purpose Although widely used, there is a lack of evidence concerning the diagnostic accuracy of C-reactive protein (CRP) and white blood cell counts (WBCs) in the postoperative period. The aim of this study was to evaluate the diagnostic accuracy of CRP and WBCs in predicting postoperative inflammatory complications after open resection of colorectal cancer. Methods In this retrospective study, clinical data and the CRP and WBCs, routinely measured until postoperative day 5 (POD 5), were available for 1,187 patients who underwent colorectal cancer surgery between 1997 and 2009. Using the receiver-operating characteristic (ROC) methodology, the diagnostic accuracy was evaluated according to the area under the curve (AUC). Results Three hundred forty-seven patients (29.2%; 95% CI, 26.7-31.9%) developed various inflammatory complications. Anastomotic leakage occurred in 8.0% (95% CI, 6.1-9.1%) of patients. The CRP level on POD 4 (AUC 0.76; 95% CI, 0.71-0.81) had the highest diagnostic accuracy for the early detection of inflammatory complications. With a cutoff of 123 mg/l, the sensitivity was 0.66 (95% CI, 0.56-0.74), and the specificity was 0.77 (95% CI, 0.71-0.82). The diagnostic accuracy of the WBC was significantly lower compared to CRP. Conclusion Measurement of CRP on POD 4 is recommended to screen for inflammatory complications. CRP values above 123 mg/l on POD 4 should raise suspicion of inflammatory complications, although the discriminatory performance was insufficient to provide a single threshold that could be used to correctly predict inflammatory complications in clinical practice. WBC measurement contributes little to the early detection of inflammatory complications.
Introduction
Septic complications after colorectal resection for cancer are observed in up to 40% [1, 2] of cases and consist mainly of surgical site infections (up to 40%), pulmonary infections (10%) and urinary infections (5%) [3] . Anastomotic leakage is the most feared complication after colorectal cancer resection and is frequently diagnosed late in the postoperative period, after a mean of 13 days [4] . Other inflammatory complications are diagnosed as late as the ninth postoperative day [5] . Although measurements of C-reactive protein (CRP) and white blood cell counts (WBCs) are performed extensively, there is still a lack of evidence about their diagnostic value in predicting inflammatory complications, and the optimal timing for such measurements after colorectal cancer surgery remains unknown. It has been reported that for patients with inflammatory complications after colorectal surgery, pre-emptive antibiotic therapy may significantly improve outcomes [6] . Furthermore, in sepsis, early goal-directed therapy is essential in improving survival [7] . Therefore, there is a need for the early detection of infectious complications to facilitate the initiation of adequate treatment as soon as possible. Although procalcitonin levels seem to have a higher diagnostic accuracy than CRP in the detection of inflammatory complications, CRP is the most popular and most widely available marker of the acute inflammatory response [6, 8, 9] . Peak serum levels of CRP lag approximately 2 days behind the initiation of an acute systemic inflammatory response, and its half-life of approximately 19 h is short enough to establish CRP as a valuable marker of inflammatory processes [10] [11] [12] .
The literature on the diagnostic value of CRP and WBCs after colorectal cancer surgery is limited. Based on small heterogeneous patient groups, some studies failed to demonstrate a relevant diagnostic value of CRP in the detection of inflammatory complications [13] . Other studies did not apply the statistically adequate receiver-operating characteristic (ROC) analysis, probably because of the small sample sizes [5, 14] . In other studies, CRP and WBCs were examined only every other day [15] . One recently published study examining a small cohort estimated an optimal cut-off value of 145 mg/l for CRP on postoperative day 4 (POD 4), which yielded a sensitivity of 0.85 and a specificity of 0.86; the WBC was not assessed [16] . Other studies focused on postoperative changes in CRP rather than on absolute values and identified a lack of decline as a prognostic marker of anastomotic leakage [17] .
The present study aimed to assess the diagnostic accuracy of absolute CRP and WBC values and their dynamics in the early detection of inflammatory complications from POD 1 to POD 5 in a series of unselected consecutive patients after colorectal cancer resection.
Patients and methods
The study design was retrospective. A computer search of the institutional database identified a total of 1,238 patients with histologically proven colorectal adenocarcinoma who underwent primary colorectal cancer resection between January 1997 and August 2009. All patients routinely received preoperative antibiotic prophylaxis (500 mg metronidazole i.v. and 2,000 mg cefamandole i.v. for 60 min before surgery) and anticoagulation with low-molecular-weight heparin, in accordance with hospital guidelines.
Data collection and definitions
Data on patient demographics, operative details, postoperative mortality, morbidity and histological results were gathered retrospectively from the medical records. Mortality was defined as any death that occurred on or before the 30th postoperative day. Anastomotic leakage was defined as the presence of an intra-abdominal abscess with confirmation by rectal examination, sigmoidoscopy, extravasation of endoluminally administered water-soluble contrast on radiography or computed tomography or confirmation upon return to the operating room. Wound infections and intra-abdominal abscesses that were not related to anastomotic leakages were recorded according to the diagnosis in the medical records or operation protocols. Pneumonia was recorded when explicitly stated as a diagnosis in the medical records or as a radiological finding. Urinary infections, central line infections, Clostridium difficile colitis, or other infections were recorded when explicitly stated in the medical records or when there were bacteriological findings, independent of treatment.
CRP and WBC measurement CRP concentrations were measured using an automated analytical system (Unicel DxC 800, Beckman Coulter, reference range <8 mg/l). WBCs were performed using an automated haematology analyzer (Sysmex XE-5,000, reference range 4-10 G/l). For CRP, the range of measurement was limited to between 3 and 300 mg/l until August 2005. Subsequent to that, the measurement range was extended to between 1 and 500 mg/l. Therefore, all CRP values exceeding 300 mg/l were designated as 300 mg/l, and values lower that 3 mg/l were designated as 3 mg/l.
Statistical analysis and authorization
Statistical analysis was performed using the R environment (http://www.rproject.org). Two-sided p values <0.05 were considered statistically significant. Continuous data are expressed as the mean±standard deviation or interquartile range (IQR), as appropriate. Confidence intervals (95% CI) of binominal proportions were estimated according to a modified Wilson's method [18] .
The diagnostic accuracy was evaluated with the area under the curve (AUC), using the ROC methodology [19] . The AUCs were computed using the non-parametric trapezoidal method, and their 95% confidence limits were computed according to method established by DeLong [20] . Cut-off values were estimated by optimizing the Youden index. Nonparametric 95% CIs for the cut-off values were computed with bootstrapping using the percentile method (1,999 estimates) [21, 22] .
The study was approved by the Swiss Federal Expert Commission for Physician Confidentiality and by the institutional ethical review board. It was registered at www.clinicaltrials.gov (NCT01221324). Table 4 . Compared to the diagnostic accuracy of WBCs, CRP had a significantly greater AUC on POD 2 (p=0.034), POD 3 (p=0.003) and POD 4 (p<0.001), but not on POD 5 (p=0.415).
Results

Exclusion
The highest diagnostic accuracy was observed for CRP measured on POD 4, with an AUC of 0.76 (95% CI, 0.71-0.81). The statistically optimal cut-off value for CRP to discriminate between patients with and without inflammatory complications on POD 4 was 123 mg/l (95% CI, 94-160 mg/l). Of 103 patients with inflammatory complications, 68 had CRP values above this cutoff, such that the sensitivity was 0.66 (95% CI, 0.56-0.74). In 162 of 211 patients without inflammatory complications, CRP values did not exceed 123 mg/l, yielding a specificity of 0.77 (95% CI, 0.71-0.82). In Fig. 2 , the sensitivity and specificity of CRP measurement on POD 4 in predicting inflammatory complications are plotted over the entire range of CRP measurements. The cut-off value for a sensitivity of 90% was estimated to be 56 mg/l (95% CI, 42-70 mg/l); for a specificity of 90%, the cut-off value was 200 mg/l (95% CI, 151-243 mg/l).
Applying the cut-off value of 123 mg/l for CRP on POD 4, the positive predictive value (PPV) was 0.54 (95% CI, 0.48-0.59), and the negative predictive value (NPV) was 0.85 (95% CI, 0.80-0.88) after adjusting for the observed prevalence of 29.2% in the entire study population. For an NPV of 0.90, the corresponding cut-off value was 54 mg/l. In 71 of 314 patients (22.6%), CRP on POD 4 did not exceed this value. Seven of these patients were classified as false negatives, but developed only less serious complica- 
Subgroup analysis for anastomotic leakage
In a subgroup analysis, the diagnostic accuracy of CRP and WBC levels in predicting anastomotic leakage was analysed in the 1,115 patients who received anastomoses. Anastomotic leakage was highly correlated with other inflammatory complications; 54 of 89 (60.7%; 95% CI, 50.3-70.2%) patients with anastomotic leakage developed other inflammatory complications. The detailed results for the intrinsic diagnostic accuracy of CRP in detecting anastomotic leakage are provided in Table 5 . CRP levels had a significant predictive value for anastomotic leakage on POD 3 to POD 5, but WBC measurements had a significant predictive value for anastomotic leakage on POD 5 only. CRP levels had the highest diagnostic accuracy on POD 4. Applying the cut-off value of 143 mg/l and adjusting for a prevalence of 8%, the PPV on POD 4 was 0.19 (95% CI, 0.14-0.23), and the NPV was 0.97 (95% CI, 0.94-0.99). In Fig. 3 , the sensitivity and specificity of CRP measurement on POD 4 in detecting anastomotic leakage are plotted over the entire range of CRP values.
Discussion
The early identification of patients who are at risk for inflammatory complications is undoubtedly of high clinical value. The prevalence of inflammatory complications in this study was as high as 29.2%, with an 8.0% prevalence of anastomotic leakage. The mortality of 2.2% in this study is comparable to the outcomes in other studies [24, 25] , and it was significantly higher among patients with inflammatory complications. Consistent with previous reports, leakages were diagnosed after a median of nine postoperative days (IQR, 6-14 days) [4, 5] . As the main finding, CRP measured on POD 4 was the only marker of inflammatory complications and anastomotic leakage that could be rated as moderately accurate, with AUCs of 0.76 and 0.77, respectively [26] . Two other studies found the highest diagnostic accuracy of CRP to be obtained on POD 5, although one of Analysis of receiver-operating characteristic (ROC) curves for inflammatory complications; AUC was estimated non-parametrically with the trapezoidal method Table provides case loads with CRP/WBC values, prevalence of inflammatory complications, optimal cut-off value maximizing the Youden Index, true-positive (TP), false-negative (FN), truenegative (TN) and false-positive (FP) cases, as well as the sensitivity, and specificity for the cut-off value and p AUC for discrimination between positive and negative cases. Area under the ROC curve (AUC), cuff-off values, sensitivity, specificity and AUC are provided with 95% confidence intervals those studies did not assess CRP on POD 4 [15, 16] . The AUCs were higher than in the present study; however, in one study, patients who had undergone laparoscopic operations were included [16] , whereas the other study assessed a heterogeneous patient cohort that included patients with cancer, diverticulitis and Crohn's/ulcerative colitis [15] . Increasing CRP between POD 4 and POD 5 was not sensitive for inflammatory complications, but it was specific. This result is consistent with the findings of another recent study that demonstrated a lack of CRP decline as a strong prognostic marker of anastomotic leakage; however, that study did not apply the statistically adequate ROC analysis [17] . In the present study, WBC values did not contribute substantially to distinguishing between patients with and without inflammatory complications. To our knowledge, there is no other study that directly compares the diagnostic impact of CRP and WBC in detecting inflammatory complications after colorectal surgery.
To derive clinical decisions from CRP values, it is important to know that sensitivity and specificity are inversely related depending on the choice of the cut-off value. Using the statistically estimated 'optimal' cut-off value of 123 mg/l for CRP on POD 4, the sensitivity was 66%, and the specificity was 77% in predicting inflammatory complications; this corresponds to a PPV of 54% and an NPV of 85% after adjustment for a prevalence of 29.2%. The maximal achievable PPV for CRP when applying higher cut-off values was less than 70%. Therefore, the diagnostic accuracy of an increased CRP was not sufficiently high to rule in inflammatory complications in clinical practice [27] . Thus, the present data do not support Analysis of receiver-operating characteristic (ROC) curves for anastomotic leakage; AUC was estimated non-parametrically with the trapezoidal method.
Table provides case loads with CRP/WBC values, prevalence of anastomotic leakage, optimal cut-off value maximizing the Youden Index, true-positive (TP), false-negative (FN), true-negative (TN) and false-positive (FP) cases, as well as the sensitivity, and specificity, for the cut-off value and p AUC for discrimination between positive and negative cases. Area under the ROC curve (AUC), cuff-off values, sensitivity, specificity, and AUC are provided with 95% confidence intervals. the initiation of pre-emptive antibiotic treatment based solely on an elevated CRP on POD 4, as was proposed by Chromik et al. for procalcitonin [6] . In contrast, postoperative estimations of CRP are valuable in ruling out inflammatory complications. For this aim, a clinically defined cut-off value, and not the statistically estimated optimal value, should be applied. To achieve an NPV of 90%, the necessary cut-off value was 54 mg/l. Unfortunately, the evidence from the present retrospective study is not sufficiently strong to provide a distinct cut-off value with the necessary certainty. Such a cutoff should be identified and proven in large prospective studies, and the present results might serve as a benchmark.
According to the present study, in patients with CRP values exceeding 123 mg/l on POD 4, inflammatory complications will develop in approximately every other patient, and a higher CRP indicates a higher risk of inflammatory complications. When in doubt, a urinalysis, thoracic X-ray, ultrasound examination or even a CT scan should be considered in addition to a careful clinical examination. Clinical suspicion may likely arise from an elevated CRP on POD 4, although CRP measurements cannot be used to separate patients into diseased and nondiseased groups; rather, CRP values must be interpreted in the context of the whole clinical picture.
In the present study, 61% of the patients with anastomotic leakage developed other inflammatory complications. Furthermore, CRP is not specific to a particular type of inflammatory complication [12] . Therefore, it seems questionable to use this marker to predict leakages if patients with other inflammatory complications are considered non-diseased. Nevertheless, when using a CRP of 143 mg/l on POD 4 as the cut-off value, the NPV was as high as 97%, and the PPV was 19%. With an NPV of 97%, the development of anastomotic leakage can be ruled out when the CRP value on POD 4 is 143 mg/l or less. PPV is too low to rule in anastomotic leakage [27] .
In contrast to most other studies, the overall median hospital stay of 20.7±12.2 days in the present series reflects the current hospital policy in Switzerland, where reimbursement is not yet based on diagnosis-related groups (DRG). Under the special circumstances of this diagnostic study, the long hospital stay is an advantage because the detection rate for complications may be higher. This hypothesis is highlighted by the wide range of complications identified in this study. Implementation of DRG-based reimbursement and fasttrack surgery inevitably leads to shorter hospital stays. In such a context, CRP screening on POD 4 might prevent the discharge of patients who may have undetected inflammatory complications.
In interpreting the findings of the present study, it is important to consider that these results are limited to a single centre cohort between 1997 and 2009. Due to the difficulties associated with the retrospective design, this study did not assess the timing of inflammatory complications, except for anastomotic leakage. Various forms of biases are likely to have occurred in the present study, and they may have affected the selection of patients and the diagnostic performance. For instance, postoperative CRP measurements may have influenced the application of diagnostic techniques for detection of postoperative inflammatory complications. However, the retrospective study design allowed for the assessment of a large cohort that was treated according to day-to-day clinical practice. In light of the comparative effectiveness research [28, 29] guidelines, the present study and its clinically relevant approach may help clinicians with their decisions about using CRP as a diagnostic marker in patients who have undergone colorectal cancer resection.
Conclusion
Although the present study used a retrospective design, it confirmed CRP, best measured on POD 4, as a moderately accurate diagnostic marker in the prediction of postoperative inflammatory complications, including anastomotic leakage. CRP values should not be used as a 'black-and-white' decision criterion, as the diagnostic accuracy was insufficient to provide a single threshold that performed sufficiently well to correctly predict inflammatory complications in clinical practice. Interpretation of CRP values must be considered within the whole clinical scenario. Measurement of WBCs contributes little to the early detection of inflammatory complications. If postoperative CRP measurement is to be considered as a routine screen for postoperative inflammatory complications after colorectal cancer surgery, we recommend performing this test on POD 4.
